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Introduction
More than 1 billion people have been reported to be infected with at least one soil-transmitted
helminth (STH) worldwide, according to the last published report of the World Health Orga-
nization (WHO) [1]. WHO guidelines for STH control mainly encompass periodic adminis-
tration of benzimidazoles (albendazole or mebendazole) to at-risk people of the endemic areas
[1]. However, extended use of benzimidazoles could entail a great selection pressure for para-
sitic-resistant strains. In veterinary medicine, anthelmintic resistance in gastrointestinal nema-
todes has been developed in response to their excessive use, and it is currently considered a
serious threat to livestock health and welfare [2, 3]. In humans, the estimated efficacy of alben-
dazole and mebendazole against Trichuris trichiura has been observed to significantly decrease
over time [4]. This observed decrement in drug efficacy could be due to the development of
anthelmintic resistance (among other reasons such as drug quality and administration, the
increasing of drug-efficacy studies, improvements in sensitivity of diagnostic tools after treat-
ment, etc) after years of mass drug-administration campaigns, which is one of the major con-
cerns in STH control [5].
Monitoring anthelmintic efficacy trials have been traditionally done by microscopic
approaches, although it is well known that microscopy’s sensitivity may be insufficient in this
context [6, 7]. We think that DNA-detection–based tools represent an accurate alternative to
parasitological methods, and they should be evaluated and validated not only for monitoring
worm burden before and after treatment but also for detecting genetic markers related to
anthelmintic resistance.
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Monitoring infection intensity pre- and posttreatment
The cure rate (CR) and egg reduction rate (ERR) are both based on the microscopic detection
of helminth eggs or larvae in stool samples and are traditionally used as indicators for monitor-
ing drug efficacy. CR is calculated as the percentage of baseline-infected individuals that are
diagnosed as negative posttreatment. ERR refers to the reduction in the number of eggs
excreted posttreatment and is calculated using quantitative methods [6]. However, sensitivity,
being microscopy’s major limitation, especially in posttreatment-occurring low-intensity
infections, may overestimate both CR and ERR. Besides, they are observer dependent, which
leads to variations in egg counts and limits standardisation options [7].
Recently, quantitative detection of parasite-specific DNA in clinical samples by real-time
polymerase chain reaction (qPCR) tests has demonstrated substantial improvement in diag-
nostic performance as compared to microscopy, including the capability to differentiate
between hookworm species [8, 9]. However, despite its high sensitivity, qPCR has not been
frequently used for monitoring STH-infection intensity in drug-efficacy trials. Mejia and col-
leagues used multiparallel qPCR to assess Ascaris lumbricoides burden pre- and postalbenda-
zole administration in a cohort of 125 children, wherein all the participants detected positive
by qPCR at baseline were below the threshold of detection after 21 days of treatment [10]. Of
late, efficacy of a single dose of albendazole against A. lumbricoides and Necator americanus
was assessed with a pentaplex qPCR in context of a controlled deworming trial [11]. However,
in this study, the egg number in stool samples was not determined; as a result, the authors
were not able to correlate ERR with the infection intensity reduction rate based on qPCR
results [11].
Highly sensitive diagnostic methods might allow the detection of light infections posttreat-
ment and consequently aid the identification of potential resistant strains, particularly with
respect to drug-efficacy trials. However, more systematic studies are required to further
explore the exact relationship between observed parasite intensity determined by faecal egg
counts and the quantitative outcome of the qPCR [12].
Genetic markers associated with benzimidazole resistance
As discussed above, qPCR might aid in evaluating drug efficacy by accurately estimating infec-
tion intensity before and after treatment [10–11]; however, the detection of genetic resistance
markers could also predict treatment failures. Benzimidazoles bind to the colchicine binding
site of β-tubulin, thereby disrupting microtubule polymerization and leading to parasite death.
Parasite microtubules have been reported to be involved in vital functions at cellular level,
including mitosis, motility, and transport [13]. In veterinary medicine, benzimidazole resis-
tance is mainly associated with a single nucleotide polymorphism (SNP) at codon 200 of iso-
type 1 of β-tubulin–encoding gene, which results in amino-acid substitution of phenylalanine
to tyrosine (F200Y). A similar SNP at codon 167 (F167Y) or a glutamate to alanine change at
codon 198 (E198A) has been associated as a drug-resistance marker [3] (Fig 1). However, few
studies have investigated the presence, frequency, and association of these markers with benz-
imidazole resistance in human STH species.
The presence of putative benzimidazole-resistance SNPs has been studied by different
molecular methods [14–21], which are presented in Table 1.
As observed, several molecular tools designed for detecting benzimidazole-resistant SNPs
exist; however, technical and economic requirements could limit their application in low-
income countries. SmartAmp technology has reported to be less expensive and highly efficient,
and it has been also proposed as a quantitative technique [22] with potential applicability for
mass screening in limited-resource settings. However, SmartAmp is still being validated, and
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currently only two studies describe this methodology for SNPs detection in STH (Table 2).
The qualitative techniques that detect only the presence or absence of these SNPs possess a
drawback: that the frequency of resistant alleles could not be measured in a pool of eggs. Con-
versely, pyrosequencing is more precise when compared with qualitative techniques, since it
accurately determines multiple resistant allele frequencies in the same run. This technique has
been widely used for detecting benzimidazole-resistant isolates in livestock nematodes [2], and
therefore, we believe that pyrosequencing could be extremely helpful in understanding if there
is a relationship between the presence of SNPs and their frequency with benzimidazole efficacy
in STH, despite the high cost of pyrosequencing. It is expected that benzimidazole treatment
could select resistant strains, and consequently, frequencies of resistant alleles would increase
posttreatment.
With regard to these techniques’ application, qPCR was first applied to detect the changes
at codons 167 and 200 of β-tubulin gene of N. americanus [14, 21] and Ancylostoma duodenale,
respectively [14]. More recently, restriction fragment length polymorphism (RFLP)-PCR has
Fig 1. Putative benzimidazole-resistance SNP in human STHs. (A) Sequence information displayed in GenBank’s
flat file; the boxes represent exons, whereas the lines represent introns. (B) Detailed nucleotide sequence of the three
putative resistance SNPs and the amino-acid transcript at codons 167, 198, and 200. Al, Ascaris lumbricoides β-tubulin
1 sequence, partial cds (GenBank: FJ501301); cds, coding sequence; Na, Necator americanus β-tubulin 1 sequence,
complete cds (GenBank: EF392851); STH, soil-transmitted helminth; Tt, Trichuris truchiura β-tubulin 1 sequence,
complete cds (GenBank: AF034219).
https://doi.org/10.1371/journal.pntd.0007931.g001
Table 1. Characteristics of the molecular tools used for detecting putative benzimidazole-resistance SNPs in human STHs.
Cost Quantitative Strengths Weaknesses
qPCR ++ Yes • Real-time detection
• Widely used technique
• Expensive equipment
RFLP–PCR + No • Simplicity
• Widely used technique
• SNP detection limited by commercial endonucleases
• Time-consuming procedure
• Less accurate than the others
SmartAmp + No • Isothermal amplification (no thermocycler)
• Real-time detection
• High amplification efficiency
• Rapid and simple
• Need further validation
Pyrosequencing +++ Yes • High throughput
• Multiple SNP detection
• Accurate SNP frequency
• Highly expensive equipment
• Not widely available
qPCR, real-time polymerase chain reaction; RFLP–PCR, restriction fragment length polymorphism-polymerase chain reaction; STH, soil-transmitted helminth
https://doi.org/10.1371/journal.pntd.0007931.t001
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been used to study SNPs presence in N. americanus and A. lumbricoides populations in Brazil
[18]. As an alternative, SmartAmp was developed for rapid and efficient genotyping of β-tubu-
lin gene in A. lumbricoides, N. americanus, and T. trichiura [19–20]. Hence, pyrosequencing
has been successfully used for determining the presence and frequency of three SNPs in all
STH species except for A. duodenale [15–17]. Principal findings regarding genotypic benz-
imidazole resistance in STH are summarized in Table 2.
As previously described, all three SNPs (F167Y, E198A, and F200Y) have been detected in
T. trichiura and N. americanus, whereas only F167Y has been observed in A. lumbricoides.
However, most of these studies described only the presence or absence of SNPs and did not
evaluate their association with the treatment response. However, so far only F200Y of T. tri-
chiura has been noted to be associated with low response against albendazole [14, 15]. Diawara
and colleagues measured the resistant allele frequency in T. trichiura by pyrosequencing in the
stool samples collected from benzimidazole-naive populations [15] and albendazole-adminis-
tered participants [16]. In nontreated areas, genotypic resistant profile (up to 63%) was noted,
which explained the widespread suboptimal efficacy of benzimidazole against T. trichiura [15].
Moreover, a significant increase (from 3.1% to 55.3%) in F200Y frequency was observed post-
treatment, which entailed the selection of resistant genotype [16]. The obtained results were in
line with the findings observed in cases of veterinary helminths, wherein F200Y was reported
as the most common SNP implicated in benzimidazole resistance [3]. However, this assertion
must be cautiously interpreted, since the number of analyzed samples was low and the applied
methodology was not harmonized across the study sites [16].
The case of Strongyloides stercoralis and ivermectin
Despite being recognized as an important intestinal helminthiasis to incorporate into deworm-
ing campaigns, strongyloidiasis has been commonly neglected in STH interventions [21]. The
inefficiency of microscopy to detect S. stercoralis and the latter’s unique feature of internal
reproduction within the human host, makes worm burden less relevant, thereby rendering CR
as a sole efficacy indicator [23]. Therefore, quantitative molecular methods such as qPCR
would be even more important to accurately estimate the infection intensity pre- and post-
anthelmintic treatment.
Apart from this, albendazole displays low efficacy against S. stercoralis, and ivermectin is
the drug of choice [24]. Ivermectin has been extensively used in mass drug-administration
campaigns for onchocerciasis and lymphatic filariasis [25] and, together with albendazole, is
being evaluated for STH deworming campaigns due to higher efficacy of the combination,
Table 2. Summary of the results obtained by molecular tools in the detection of putative benzimidazole-resistance SNPs for human STHs.
A. lumbricoides T. trichiura N. americanus A. duodenale
F167Y E198A F200Y F167Y E198A F200Y F167Y E198A F200Y F167Y E198A F200Y
RFLP–PCR × × - - - - - ✓ ✓ - - - [18]
qPCR - - - - - - ✓ × ×/✓ - × × [14, 21]
SmartAmp ✓ × × - × ✓ × ✓ × - - - [19, 20]
Pyrosequencing ✓ × × ✓ ✓ ✓ × × ✓ - - - [15–17]
F167Y, E198A, and F200Y: putative benzimidazole-resistance SNPs at codon 167, 198, and 200, respectively.
✓: method applied and SNP detected.
×: method applied and SNP not detected.
-: method not applied for SNP detection.
qPCR, real-time polymerase chain reaction; RFLP–PCR, restriction fragment length polymorphism-polymerase chain reaction; STH, soil-transmitted helminth
https://doi.org/10.1371/journal.pntd.0007931.t002
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particularly against T. trichiura [4]. Although, low response against ivermectin has been
reported in veterinary helminths [2], we ignore the impact mass ivermectin administration
(past and future) could entail in the development of anthelmintic resistance in S. stercoralis
infections. Hence, in context of a potential widespread use of ivermectin against STH, we
think that monitoring its efficacy and ivermectin-resistance emergence becomes of utmost
importance, which has never been done so far.
Conclusions
Early detection of resistant strains is crucial for the successful performance of drug-efficacy tri-
als with anthelmintics. Despite a wide range of different molecular tools, not enough system-
atic studies have been reported that could definitively associate low drug efficacy by ERR with
the presence of anthelmintic-resistance genetic markers.
The authors of this viewpoint joined efforts in 2018 for the development of the STOP proj-
ect (Stopping Transmission Of intestinal Parasites), funded by the European & Developing
Countries Clinical Trials Partnership (EDCTP), with the main aim of moving forward with
the control and elimination of STH infections. To our knowledge, there are two similar proj-
ects that are evaluating molecular tools for monitoring drug-efficacy trials in human STH: the
DeWorm3 project, which will test the feasibility of interrupting STH transmission using bian-
nual mass drug administration targeting all age groups and with large scale application of PCR
for monitoring drug-administration campaigns [26], and the Starworms study, with the overall
aim of recommending the best diagnostic methods for monitoring drug efficacy and molecular
markers to assess anthelmintic-resistance emergence in STH-control programs [22]. In con-
trast, STOP is built around a multicenter, randomized, clinical trial for evaluating safety and
efficacy of fixed dose of ivermectin and albendazole coformulation in 1,800 STH-infected
children in Mozambique, Kenya, and Ethiopia. During the development of the trial, we will
evaluate DNA-detection–based assays for accurately estimating the efficacy of the new cofor-
mulation. Besides, we would determine the usefulness of this new drug combination against
potential STH-resistant strains in comparison with albendazole. We believe that the study of
genetic resistance should be incorporated in future evaluation of anthelmintics, especially in
drug-efficacy trials, for a better understanding of the potential impact of this problem in the
drug assessment.
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